[Federal Register Volume 80, Number 16 (Monday, January 26, 2015)]
[Notices]
[Page 3988]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-01289]



[[Page 3988]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Boehringer 
Ingelheim Chemical, Inc.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Boehringer Ingelheim Chemical, Inc. applied to be registered 
as a manufacturer of certain basic classes of controlled substances. 
The DEA grants Boehringer Ingelheim Chemical, Inc. registration as a 
manufacturer of the controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated May 28, 2014, and published 
in the Federal Register on June 4, 2014, 79 FR 32321, Boehringer 
Ingelheim Chemical, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 
23805-9372, applied to be registered as a manufacturer of certain basic 
classes of controlled substances. No comments or objections were 
submitted to this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of 
Boehringer Ingelheim Chemical, Inc. to manufacture the basic classes of 
controlled substances is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above-named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale to its customers for formulation into finished 
pharmaceuticals. In reference to methadone intermediate (9254) the 
company plans to produce methadone HCL active pharmaceutical 
ingredients (APIs) for sale to its customers.

    Dated: January 9, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01289 Filed 1-23-15; 8:45 am]
BILLING CODE 4410-09-P